September 01, 1989; 39 (9) Articles
Clozapine in the treatment of psychosis in Parkinson's disease
Joseph H. Friedman, Margaret C. Lannon
First published September 1, 1989, DOI: https://doi.org/10.1212/WNL.39.9.1219
Clozapine in the treatment of psychosis in Parkinson's disease
Joseph H. Friedman, Margaret C. Lannon
Neurology Sep 1989, 39 (9) 1219; DOI: 10.1212/WNL.39.9.1219
Citation Manager Formats
Make Comment
See Comments

Abstract
Clozapine is an antipsychotic medication that is virtually free of ertrapyramidal side effects. We report our successful treatment of 6 patients with idiopathic Parkinson's disease and various psychoses using clozapine on a chronic basis along with carbidopa/L-dopa.
- © 1989 by AAN Enterprises, Inc.
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Related Articles
- No related articles found.